APLN and obesity due to melanocortin 4 receptor deficiency: In retrospective exploratory research, increased tumor apelin expression and obesity were independently linked to lower pathological complete response rates in 62 early BCa patients treated with taxane and anthracycline-based neoadjuvant chemotherapy.